Terms: = Liver cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Staging
370 results:
1. Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC staging.
Dong H; Yang L; Shaofeng D; Lili G
Technol Cancer Res Treat; 2024; 23():15330338241245943. PubMed ID: 38660703
[TBL] [Abstract] [Full Text] [Related]
2.
Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
[TBL] [Abstract] [Full Text] [Related]
3. SBRT vs. Y90: HCC Treatment Outcomes and Costs.
deBettencourt MF; Liu Y; Cotler SJ; Molvar CA; Abdelrahman T; Thomas TO
Am J Clin Oncol; 2024 Mar; 47(3):99-104. PubMed ID: 37981697
[TBL] [Abstract] [Full Text] [Related]
4. Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model-a Western European multicenter study.
Masuda Y; Yeo MHX; Burdio F; Sanchez-Velazquez P; Perez-Xaus M; Pelegrina A; Koh YX; Di Martino M; Goh BKP; Tan EK; Teo JY; Romano F; Famularo S; Ferrari C; Griseri G; Piardi T; Sommacale D; Gianotti L; Molfino S; Baiocchi G; Ielpo B
Updates Surg; 2024 Jan; 76(1):57-69. PubMed ID: 37839048
[TBL] [Abstract] [Full Text] [Related]
5. Proper position of single and large (≥5 cm) hepatocellular carcinoma in Barcelona Clinic liver cancer classification.
Kim HS; Choi SJN; Lee HK;
Medicine (Baltimore); 2023 Oct; 102(41):e34639. PubMed ID: 37832135
[TBL] [Abstract] [Full Text] [Related]
6. [
Yang L; Xu S; Cheng L; Gao C; Cao S; Chang Z; Wang K
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4051-4063. PubMed ID: 37542659
[TBL] [Abstract] [Full Text] [Related]
7. A Machine Learning Method to Identify the Risk Factors for liver Fibrosis Progression in Nonalcoholic Steatohepatitis.
Suárez M; Martínez R; Torres AM; Torres B; Mateo J
Dig Dis Sci; 2023 Sep; 68(9):3801-3809. PubMed ID: 37477764
[TBL] [Abstract] [Full Text] [Related]
8.
Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
[TBL] [Abstract] [Full Text] [Related]
9. Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in staging POSTTEXT and Vascular Involvement.
Gong XH; Feng MX; Zhuang ZG; Yan YQ; Wang L; Ren HN; Zhu Y; Song Y; Qian LJ; Xu JR; Zhou Y; Xia Q
J Magn Reson Imaging; 2024 Mar; 59(3):1034-1042. PubMed ID: 37272790
[TBL] [Abstract] [Full Text] [Related]
10. Superior Tumor Detection for
Pabst KM; Trajkovic-Arsic M; Cheung PFY; Ballke S; Steiger K; Bartel T; Schaarschmidt BM; Milosevic A; Seifert R; Nader M; Kessler L; Siveke JT; Lueckerath K; Kasper S; Herrmann K; Hirmas N; Schmidt HH; Hamacher R; Fendler WP
J Nucl Med; 2023 Jul; 64(7):1049-1055. PubMed ID: 37024301
[TBL] [Abstract] [Full Text] [Related]
11. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
Vali Y; Lee J; Boursier J; Petta S; Wonders K; Tiniakos D; Bedossa P; Geier A; Francque S; Allison M; Papatheodoridis G; Cortez-Pinto H; Pais R; Dufour JF; Leeming DJ; Harrison SA; Chen Y; Cobbold JF; Pavlides M; Holleboom AG; Yki-Jarvinen H; Crespo J; Karsdal M; Ostroff R; Zafarmand MH; Torstenson R; Duffin K; Yunis C; Brass C; Ekstedt M; Aithal GP; Schattenberg JM; Bugianesi E; Romero-Gomez M; Ratziu V; Anstee QM; Bossuyt PM;
Lancet Gastroenterol Hepatol; 2023 Aug; 8(8):714-725. PubMed ID: 36958367
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic value of the GPAT/AGPAT gene family in hepatocellular carcinoma and its role in the tumor immune microenvironment.
Wen P; Wang R; Xing Y; Ouyang W; Yuan Y; Zhang S; Liu Y; Peng Z
Front Immunol; 2023; 14():1026669. PubMed ID: 36845084
[TBL] [Abstract] [Full Text] [Related]
13. Solid Pseudopapillary Neoplasms of the Pancreas: Clinicopathologic Analysis and a Predictive Model.
Chen J; Zong L; Wang P; Liu Y; Zhang H; Chang X; Lu Z; Li W; Ma Y; Yu S; Chen J
Mod Pathol; 2023 Jun; 36(6):100141. PubMed ID: 36813115
[TBL] [Abstract] [Full Text] [Related]
14. ADAM10 Gene Polymorphism and Its Relationship to Hepatocellular Carcinoma in Egyptian HCV Patients Receiving Direct-Acting Antiviral Therapies (DAAs).
Ghanem S; El Gedawy G; Yehia S; Bedair H; Awad S; Abdel-Razek W; Elhelbawy M; El-Sabaawy D; Elfert AY
Asian Pac J Cancer Prev; 2023 Jan; 24(1):149-155. PubMed ID: 36708563
[TBL] [Abstract] [Full Text] [Related]
15. Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma.
Feng X; Zhang L; Niu H; Zhang H; Yang L; Wen Y; Chen SY; Shi Y; He Z; Yu L; Wang Y; Huang X; Wang Z; Qin M; Wen X; Zhang Z; Song J; Zheng Z; Yin H; Zhang H; Ma L; Wei J; Wu X; Zhang L; Zhao Y; Lu Q; Xiao H; Liu T; Fang P; Wei L; Gandhi RT; Dong J
Asia Pac J Clin Oncol; 2024 Apr; 20(2):319-322. PubMed ID: 36658669
[TBL] [Abstract] [Full Text] [Related]
16. Serological indices and ultrasound variables in predicting the staging of hepatitis B liver fibrosis: A comparative study based on random forest algorithm and traditional methods.
Xie D; Ying M; Lian J; Li X; Liu F; Yu X; Ni C
J Cancer Res Ther; 2022 Dec; 18(7):2049-2057. PubMed ID: 36647969
[TBL] [Abstract] [Full Text] [Related]
17. A Review on the Concepts for Initially Unresectable liver Tumors - Bridge to Surgery.
Andacoglu O; Ozkan O; Sekmen U; Dibekoglu C; Tokat Y
Chirurgia (Bucur); 2022 Dec; 117(6):635-642. PubMed ID: 36584055
[TBL] [Abstract] [Full Text] [Related]
18. Yttrium-90 Radioembolization: Current Indications and Outcomes.
Hamad A; Aziz H; Kamel IR; Diaz DA; Pawlik TM
J Gastrointest Surg; 2023 Mar; 27(3):604-614. PubMed ID: 36547759
[TBL] [Abstract] [Full Text] [Related]
19. Nomogram-based development and evaluation for predictions of 30-day and 1-year survival in patients with spontaneously ruptured hepatocellular carcinoma.
Wang P; Yang S; Li C; Han X; Hong D; Shao H
BMC Cancer; 2022 Nov; 22(1):1177. PubMed ID: 36376820
[TBL] [Abstract] [Full Text] [Related]
20. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
[TBL] [Abstract] [Full Text] [Related]
[Next]
